NCT04821843 2026-01-21
Neoadjuvant Treatment Modalities in Esophageal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3 Recruiting
Clinical Trials
38 trialsNCT07046221 2025-07-20
Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT06476067 2025-07-11
Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma
City of Hope Medical Center
Recruiting
NCT04958720 2025-07-03
AGAMENON
Fundación Sociedad Española de Oncologia Médica
Recruiting
NCT06906887 2025-06-29
PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer
Medical College of Wisconsin
Phase 2 Recruiting
NCT07000253 2025-06-02
OMEC-5
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 2/3 Not yet recruiting
NCT06960889 2025-05-07
A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients
Nanfang Hospital, Southern Medical University
Active not recruiting
NCT02972372 2025-02-10
CELAEC
The First Affiliated Hospital of Henan University of Science and Technology
Phase NA Recruiting
NCT06281860 2024-02-28
PITHAC
Centre Hospitalier Universitaire Vaudois
Phase 1 Unknown
NCT02465736 2024-01-16
Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)
Sun Yat-sen University
Phase 3 Unknown
NCT00551759 2023-07-03
Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
Eastern Cooperative Oncology Group
Phase 2 Terminated
NCT00003237 2023-06-22
Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT04809870 2023-05-23
Esophagectomy in Patients With Liver Cirrhosis
Universitätsklinikum Hamburg-Eppendorf
Completed
NCT03544736 2023-03-22
Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC)
Oslo University Hospital
Phase 1/2 Active not recruiting
NCT05540119 2022-09-19
SOEGAS
Karolinska Institutet
Unknown
NCT00393068 2022-03-02
Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer
SCRI Development Innovations, LLC
Phase 2 Completed
NCT03529266 2021-08-24
PLACE020
Sun Yat-sen University
Phase 2 Completed
NCT03151642 2021-04-26
A PILOT STUDY OF DIFFUSION WEIGHTED MRI TO ASSESS ESOPHAGEAL TUMOR RESONSE TO NEOADJUVANT CHEMORADIATION
Abramson Cancer Center at Penn Medicine
Completed
NCT01561014 2018-07-02
Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Wake Forest University Health Sciences
Phase 1 Completed
NCT03428074 2018-05-21
A Observational Study to Compare Effectiveness and Safety of the Surgeries in Patients With Esophageal Cancer
Chinese PLA General Hospital
Completed
NCT03415815 2018-01-30
An Observational Study to Evaluate Lymph Metastases and Prognoses of the Patients With Esophageal Cancer
Henan Cancer Hospital
Unknown
NCT00848783 2018-01-08
Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers
NYU Langone Health
Phase 2 Terminated
NCT00400114 2017-05-08
Sutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal Cancer
University Health Network, Toronto
Phase 2 Completed
NCT02938195 2016-10-19
Phase II Study of Neo-adjuvant Chemoradiotherapy for Squamous Cell Esophageal Cancer
Shanghai Chest Hospital
Phase 2 Unknown
NCT02891083 2016-09-07
Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer
Shanghai Chest Hospital
Phase 3 Unknown
NCT00176800 2016-08-22
Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT00003118 2016-07-04
Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00319735 2016-04-28
Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas
Hoosier Cancer Research Network
Phase 2 Completed
NCT02598687 2016-04-21
Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer.
Maastricht Radiation Oncology
Phase 1 Withdrawn
NCT00737438 2016-02-03
Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00525915 2015-02-09
Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01843829 2014-03-24
NeoSCOPE
Velindre NHS Trust
Phase 2 Unknown
NCT00258297 2013-10-16
Gefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By Surgery
University of Rochester
Phase 2 Terminated
NCT00002951 2013-09-05
Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer
University of Chicago
Phase 2 Completed
NCT00003087 2013-06-25
Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the Esophagus
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00002984 2012-05-24
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus
UNC Lineberger Comprehensive Cancer Center
Phase 1/2 Completed
NCT00520091 2012-05-18
Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancer
UNC Lineberger Comprehensive Cancer Center
Phase 2 Completed
NCT00154804 2007-08-23
CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal Cancer
National Taiwan University Hospital
Phase 2 Completed